Chemical synthesis of the third WW domain of TCERG 1 by native chemical ligation

Journal of Peptide Science

Volumn 17, Issue 9, 2011, Pages 644-649

  Fidan, Zerrin ^a   Younis, Aylin ^a   Schmieder, Peter ^b   Volkmer, Rudolf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

CD spectroscopy; Human ca150 transcription factor; Human transcription elongation regulator 1; Native chemical ligation; TCERG 1; WW domain

Indexed keywords

AMINO ACID; MESSENGER RNA; MONOMER; OLIGOPEPTIDE; RNA POLYMERASE; TRANSCRIPTION ELONGATION FACTOR; TRANSCRIPTION ELONGATION REGULATOR 1; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; CHEMISTRY; LIGATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SYNTHESIS;

AMINO ACID SEQUENCE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTIONAL ELONGATION FACTORS;

EID: 79961169670     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1383     Document Type: Article

References (24)

1. Zarrinpar A, Bhattacharyya RP, Lim WA. The structure and function of proline recognition domains. Sci. STKE 2003; (179): RE8.
2. Macias MJ, Wiesner S, Sudol M. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett. 2002; 513: 30-37.
3. Sudol M. The WW domain. In Modular Protein Domains. Cesareni G, Gimona M, Sudol M, Yaffe M (eds). Wiley-VCH: Weinheim, 2005; 59-72.
4. Macias MJ, Hyvönen M, Baraldi E, Schultz J, Sudol M, Saraste M, Oschkinat H. Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature 1996; 382: 646-649.
5. Koepf EK, Petrassi HM, Sudol M, Kelly JW. WW: an isolated three-stranded antiparallel beta-sheet domain that unfolds and refolds reversibly; evidence for a structured hydrophobic cluster in urea and GdnHCl and a disordered thermal unfolded state. Protein Sci. 1999; 8: 841-853.
6. Jager M, Deechongkit S, Koepf EK, Nguyen H, Gao J, Powers ET, Gruebele M, Kelly JW. Understanding the mechanism of beta-sheet folding from a chemical and biological perspective. Biopolymers 2008; 90: 751-758.
7. Deechongkit S, Nguyen H, Jager M, Powers ET, Gruebele M, Kelly JW. Beta-sheet folding mechanisms from perturbation energetics. Curr. Opin. Struct. Biol. 2006; 16: 94-101.
8. Ramirez-Espain X, Ruiz L, Martin-Malpartida P, Oschkinat H, Macias MJ. Structural characterization of a new binding motif and a novel binding mode in group 2 WW domains. J. Mol. Biol. 2007; 373:1255- 1268.
9. Ferguson N, Becker J, Tidow H, Tremmel S, Sharpe TD, Krause G, Flinders J, Petrovich M, Berriman J, Oschkinat H, Fersht AR. General structural motifs of amyloid protofilaments. Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 16248-16253.
10. Przezdziak J, Tremmel S, Kretzschmar I, Beyermann M, Bienert M, Volkmer-Engert R. Probing the ligand-binding specificity and analyzing the folding state of SPOT-synthesized FBP28 WW domain variants. ChemBioChem 2006; 7: 780-788.
11. Otte L, Wiedemann U, Schlegel B, Pires JR, Beyermann M, Schmieder P, Krause G, Volkmer-Engert R, Schneider-Mergener J, Oschkinat H. WW domain sequence activity relationships identified using ligand recognition propensities of 42 WW domains. Protein Sci. 2003; 12: 491-500.
12. Carty SM, Goldstrohm AC, Sune C, Garcia-Blanco MA, Greenleaf AL. Protein-interaction modules that organize nuclear function: FF domains of CA150 bind the phosphoCTD of RNA polymerase II. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 9015-9020.
13. Goldstrohm AC, Albrecht TR, Sune C, Bedford MT, Garcia-Blanco MA. The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1. Mol. Cell. Biol. 2001; 21: 7617-7628.
14. Smith MJ, Kulkarni S, Pawson T. FF domains of CA150 bind transcription and splicing factors through multiple weak interactions. Mol. Cell. Biol. 2004; 24: 9274-9285.
15. Sánchez-Alvarez M, Goldstrohm AC, Garcia-Blanco MA, Suñé C. Human transcription elongation factor CA150 localizes to splicing factor-rich nuclear speckles and assembles transcription and splicing components into complexes through its amino and carboxyl regions. Mol. Cell. Biol. 2006; 26: 4998-5014.
16. Pearson JL, Robinson TJ, Muñoz MJ, Kornblihtt AR, Garcia-Blanco MA. Identification of the cellular targets of the transcription factor TCERG1 reveals a prevalent role in mRNA processing. J. Biol. Chem. 2008; 283: 7949-7961.
17. Lin KT, Lu Rm, Tarn WY. The WW domain-containing proteins interact with the early spliceosome and participate in pre-mRNA splicing in vivo. Mol. Cell. Biol. 2004; 24: 9176-9185.
18. Holbert S, Denghien I, Kiechle T, Rosenblatt A, Wellington C, Hayden MR, Margolis RL, Ross CA, Dausset J, Ferrante RJ, Neri C. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc. Natl. Acad. Sci. U.S.A. 2001; 98: 1811-1816.
19. Arango M, Holbert S, Zala D, Brouillet E, Pearson J, Regulier E, Thakur AK, Aebischer P, Wetzel R, Deglon N, Neri C. CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity. J. Neurosci. 2006; 26: 4649-4659.
20. Goldstrohm AC, Greenleaf AL, Garcia-Blanco MA. Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. Gene 2001; 277: 31-47.
21. Wellings DA, Atherton E. Standard Fmoc protocols. Methods Enzymol. 1997; 289: 44-67.
22. Tremmel S, Beyermann M, Oschkinat H, Bienert M, Naumann D, Fabian H. 13C-labeled tyrosine residues as local IR probes for monitoring conformational changes in peptides and proteins. Angew. Chem. Int. Ed. Engl. 2005; 44: 4631-4635.
23. Dawson PE, Muir TW, Clark-Lewis I, Kent SB. Synthesis of proteins by native chemical ligation. Science 1994; 266: 776-779.
24. Eggelkraut-Gottanka R, Klose A, Beck-Sickinger AG, Beyermann M. Peptide (alpha) thioester formation using standard Fmoc-chemistry. Tetrahedron Lett. 2003; 44: 3551-3554.